IMUX
Price
$0.90
Change
-$0.00 (-0.00%)
Updated
Aug 8, 10:40 AM (EDT)
Capitalization
86.45M
90 days until earnings call
REVB
Price
$2.43
Change
-$0.12 (-4.71%)
Updated
Aug 8, 10:53 AM (EDT)
Capitalization
3.91M
Interact to see
Advertisement

IMUX vs REVB

Header iconIMUX vs REVB Comparison
Open Charts IMUX vs REVBBanner chart's image
Immunic
Price$0.90
Change-$0.00 (-0.00%)
Volume$2.62K
Capitalization86.45M
Revelation Biosciences
Price$2.43
Change-$0.12 (-4.71%)
Volume$100
Capitalization3.91M
IMUX vs REVB Comparison Chart in %
Loading...
IMUX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMUX vs. REVB commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMUX is a Hold and REVB is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (IMUX: $0.90 vs. REVB: $2.55)
Brand notoriety: IMUX and REVB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMUX: 104% vs. REVB: 4%
Market capitalization -- IMUX: $86.45M vs. REVB: $3.91M
IMUX [@Biotechnology] is valued at $86.45M. REVB’s [@Biotechnology] market capitalization is $3.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMUX’s FA Score shows that 0 FA rating(s) are green whileREVB’s FA Score has 2 green FA rating(s).

  • IMUX’s FA Score: 0 green, 5 red.
  • REVB’s FA Score: 2 green, 3 red.
According to our system of comparison, both IMUX and REVB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMUX’s TA Score shows that 5 TA indicator(s) are bullish while REVB’s TA Score has 5 bullish TA indicator(s).

  • IMUX’s TA Score: 5 bullish, 5 bearish.
  • REVB’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, REVB is a better buy in the short-term than IMUX.

Price Growth

IMUX (@Biotechnology) experienced а -4.03% price change this week, while REVB (@Biotechnology) price change was +2.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Reported Earning Dates

IMUX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMUX($86.4M) has a higher market cap than REVB($3.91M). IMUX YTD gains are higher at: -9.780 vs. REVB (-88.476). REVB has higher annual earnings (EBITDA): -8.14M vs. IMUX (-100.85M). REVB has less debt than IMUX: REVB (0) vs IMUX (975K). IMUX (0) and REVB (0) have equivalent revenues.
IMUXREVBIMUX / REVB
Capitalization86.4M3.91M2,208%
EBITDA-100.85M-8.14M1,239%
Gain YTD-9.780-88.47611%
P/E RatioN/AN/A-
Revenue00-
Total Cash14.3MN/A-
Total Debt975K0-
FUNDAMENTALS RATINGS
IMUX: Fundamental Ratings
IMUX
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMUXREVB
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
75%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
67%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
59%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
48%
Advances
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
71%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
42%
View a ticker or compare two or three
Interact to see
Advertisement
IMUX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRNR4.210.10
+2.43%
Interactive Strength Inc
VNET8.150.14
+1.75%
VNET Group
LAMR124.940.38
+0.31%
Lamar Advertising Company
GCBC22.78-0.81
-3.43%
Greene County Bancorp
DTI2.10-0.18
-7.89%
Drilling Tools International Corp

IMUX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMUX has been loosely correlated with NTLA. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if IMUX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMUX
1D Price
Change %
IMUX100%
-7.88%
NTLA - IMUX
39%
Loosely correlated
+0.88%
PLRX - IMUX
36%
Loosely correlated
-0.59%
ERAS - IMUX
35%
Loosely correlated
+2.10%
IPSC - IMUX
34%
Loosely correlated
-2.43%
ORIC - IMUX
34%
Loosely correlated
-2.53%
More

REVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, REVB has been loosely correlated with GNPX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if REVB jumps, then GNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REVB
1D Price
Change %
REVB100%
+2.00%
GNPX - REVB
48%
Loosely correlated
+0.64%
TCRT - REVB
46%
Loosely correlated
-8.45%
OGEN - REVB
34%
Loosely correlated
-0.76%
IMUX - REVB
32%
Poorly correlated
-7.88%
TOVX - REVB
31%
Poorly correlated
-0.08%
More